BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2463063)

  • 1. [Use of radioimmunoanalysis for tumor markers in the diagnosis of carcinoma of the testes and prostate].
    Kausitz J
    Bratisl Lek Listy; 1988 Oct; 89(10):715-24. PubMed ID: 2463063
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunodetection of primary and secondary germ cell tumors.
    Van Cangh PJ; Ferrant A; Ninane J; Humblet Y; Deckers C
    Prog Clin Biol Res; 1985; 203():127-38. PubMed ID: 2421326
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
    Schwartz MK
    Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metastasis and markers].
    Trinchieri A; Rovera F; Longo G; Del Nero A; Zanetti G; Austoni E
    Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):27-30. PubMed ID: 1373913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of markers AFP, HCG and LDH in advanced germ cell tumors before and after cytostasis resp.
    Jaeger N; Vahlensieck W
    Prog Clin Biol Res; 1985; 203():107-16. PubMed ID: 2421323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor markers in urologic neoplasms].
    Wirth M; Grups JW; Frohmüller H
    Fortschr Med; 1986 Sep; 104(35):647-50. PubMed ID: 3021605
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor markers in urologic cancer.
    Javadpour N
    Urology; 1980 Aug; 16(2):127-36. PubMed ID: 6157242
    [No Abstract]   [Full Text] [Related]  

  • 8. A multivariate analysis of prognostic factors in advanced stage of non seminomatous germ cell tumors of the testis (NSGCTT).
    Droz JP; Kramar A; Caillaud JM; Bellet D; Wibault P; Court BH
    Prog Clin Biol Res; 1985; 203():269-70. PubMed ID: 2421329
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
    Kausitz J; Ondrus D; Belan V; Matoska J
    Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and cellular biologic tumor markers in patients with urologic cancer.
    Javadpour N
    Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular cancer: role of biological tumor markers.
    Pearson JC; Spaulding JT; Friedman MA
    Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of tumor markers in nonseminomatous germ cell tumor of the testis.
    Kulkarni JN; Kamat MR
    Eur Urol; 1993; 24(2):166-71. PubMed ID: 7690705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor markers and pathology of testicular tumors.
    Mostofi FK
    Prog Clin Biol Res; 1984; 153():69-87. PubMed ID: 6206511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
    Lancet; 1978 Nov; 2(8098):1042. PubMed ID: 82048
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemistry of germ cell tumors of the testis. Study of beta HCG and AFP.
    Caillaud JM; Bellet D; Carlu C; Droz JP
    Prog Clin Biol Res; 1985; 203():139-40. PubMed ID: 2421327
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor markers in testicular cancer.
    Catalona WJ
    Urol Clin North Am; 1979 Oct; 6(3):613-28. PubMed ID: 92089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monitoring clinical stages of testicular tumors using markers].
    Base J
    Rozhl Chir; 1989 Nov; 68(11):733-9. PubMed ID: 2483593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor volume, CT scan, lymphography, sonography, intravenous pyelography, and tumor markers in testis tumors.
    Wilbert DM; Klose KJ; Alken P; Jacobi GH; Hohenfellner R
    Urol Int; 1989; 44(1):15-9. PubMed ID: 2473563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor markers in urology.
    Grossman HB
    Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.